MedKoo Cat#: 531389 | Name: PD-85639
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

PD-85639 is a voltage-gated sodium (Na+) channel blocker (75% in 10 min & >95% in 25 min blockage of Na+ current by 25 μM PD85,639; whole-cell patch clamp using primary rat brain neurons) that is shown to target rat brain Nav1.2 with simultaneous high- and low-affinity modes of binding (EC50 = 56 nM/40% & 20 μM/60% at pH 9.0, 5 nM/28% & 3 μM/72% at pH 7.4, against 2 nM [3H]-PD85,639 for binding rat brain synaptosomes; EC50 = 17 nM/39% & 10 μM/61% using at pH 9.0 using rat brain synaptosome membranes) and a fast kinetic (t1/2 = 1.2 at 4°C, <0.5 min at 25°C), competitive against the local anesthetic Na+ channel blockers tetracaine, bupivacaine, and mepivacaine, as well as Na+ channel activators veratridine and batrachotoxin (K1 = 0.26 μM against 5 nM [3H]-BTX for binding rat neocrotical membranes).

Chemical Structure

PD-85639
PD-85639
CAS#149838-21-1 (free base)

Theoretical Analysis

MedKoo Cat#: 531389

Name: PD-85639

CAS#: 149838-21-1 (free base)

Chemical Formula: C24H32N2O

Exact Mass: 364.2515

Molecular Weight: 364.53

Elemental Analysis: C, 79.08; H, 8.85; N, 7.68; O, 4.39

Price and Availability

Size Price Availability Quantity
5mg USD 450.00
25mg USD 900.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Synonym
PD-85639; PD 85639; PD85639; PD-85639 free base;
IUPAC/Chemical Name
N-[3-(2,6-Dimethyl-1-piperidinyl)propyl]-α-phenylbenzeneacetamide
InChi Key
BPZBEIHSHWNWTE-UHFFFAOYSA-N
InChi Code
InChI=1S/C24H32N2O/c1-19-11-9-12-20(2)26(19)18-10-17-25-24(27)23(21-13-5-3-6-14-21)22-15-7-4-8-16-22/h3-8,13-16,19-20,23H,9-12,17-18H2,1-2H3,(H,25,27)
SMILES Code
O=C(NCCCN1C(C)CCCC1C)C(C2=CC=CC=C2)C3=CC=CC=C3
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
PD-85639 is a voltage-gated sodium (Na+) channel blocker.
In vitro activity:
PD85,639 accelerated dissociation of specifically bound batrachotoxin, consistent with an indirect allosteric interaction between these two compounds. Thus, like local anesthetics, PD85,639 inhibits binding of batrachotoxin by an allosteric mechanism. The results indicate that PD85,639 binds specifically to a local anesthetic receptor site on the Na+ channel alpha subunit that is allosterically linked to neurotoxin receptor site 2. Reference: Mol Pharmacol. 1993 Jun;43(6):955-64. https://pubmed.ncbi.nlm.nih.gov/8391120/
In vivo activity:
TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 364.53 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Ragsdale DS, Numann R, Catterall WA, Scheuer T. Inhibition of Na+ channels by the novel blocker PD85,639. Mol Pharmacol. 1993 Jun;43(6):949-54. PMID: 8391119. 2. Thomsen W, Hays SJ, Hicks JL, Schwarz RD, Catterall WA. Specific binding of the novel Na+ channel blocker PD85,639 to the alpha subunit of rat brain Na+ channels. Mol Pharmacol. 1993 Jun;43(6):955-64. PMID: 8391120.
In vitro protocol:
1. Ragsdale DS, Numann R, Catterall WA, Scheuer T. Inhibition of Na+ channels by the novel blocker PD85,639. Mol Pharmacol. 1993 Jun;43(6):949-54. PMID: 8391119. 2. Thomsen W, Hays SJ, Hicks JL, Schwarz RD, Catterall WA. Specific binding of the novel Na+ channel blocker PD85,639 to the alpha subunit of rat brain Na+ channels. Mol Pharmacol. 1993 Jun;43(6):955-64. PMID: 8391120.
In vivo protocol:
TBD
1: Obrenovitch TP. Sodium and potassium channel modulators: their role in neuroprotection. Int Rev Neurobiol. 1997;40:109-35. Review. PubMed PMID: 8989619. 2: Roufos I, Hays S, Schwarz RD. A structure-activity relationship study of novel phenylacetamides which are sodium channel blockers. J Med Chem. 1996 Mar 29;39(7):1514-20. PubMed PMID: 8691482. 3: Roufos I, Hays SJ, Dooley DJ, Schwarz RD, Campbell GW, Probert AW Jr. Synthesis and pharmacological evaluation of phenylacetamides as sodium-channel blockers. J Med Chem. 1994 Jan 21;37(2):268-74. PubMed PMID: 8295214. 4: Thomsen W, Hays SJ, Hicks JL, Schwarz RD, Catterall WA. Specific binding of the novel Na+ channel blocker PD85,639 to the alpha subunit of rat brain Na+ channels. Mol Pharmacol. 1993 Jun;43(6):955-64. PubMed PMID: 8391120. 5: Ragsdale DS, Numann R, Catterall WA, Scheuer T. Inhibition of Na+ channels by the novel blocker PD85,639. Mol Pharmacol. 1993 Jun;43(6):949-54. PubMed PMID: 8391119.